您好,欢迎访问浙江省农业科学院 机构知识库!

The inhibitory effect of vitamin K on RANKL-induced osteoclast differentiation and bone resorption

文献类型: 外文期刊

作者: Wu, Wei-Jie 1 ; Kim, Min Seuk 2 ; Ahn, Byung-Yong 3 ;

作者机构: 1.Zhejiang Acad Agr Sci, Inst Food Sci, Hangzhou 310021, Zhejiang, Peoples R China

2.Wonkwang Univ, Sch Dent, Dept Oral Physiol, Iksan 570749, Jeonbuk, South Korea

3.Chonbuk Natl Univ, Coll Environm & Bioresource Sci, Dept Oriental Med Resources, Iksan 570752, South Korea

期刊名称:FOOD & FUNCTION ( 影响因子:5.396; 五年影响因子:5.534 )

ISSN:

年卷期:

页码:

收录情况: SCI

摘要: To further understand the correlation between vitamin K and bone metabolism, the effects of vitamins K-1, menaquinone-4 (MK-4), and menaquinone-7 (MK-7) on RANKL-induced osteoclast differentiation and bone resorption were comparatively investigated. Vitamin K-2 groups (MK-4 and MK-7) were found to significantly inhibit RANKL-medicated osteoclast cell formation of bone marrow macrophages (BMMs) in a dose-dependent manner, without any evidence of cytotoxicity. The mRNA expression of specific osteoclast differentiation markers, such as c-Fos, NFATc1, OSCAR, and TRAP, as well as NFATc1 protein expression and TRAP activity in RANKL-treated BMMs were inhibited by vitamin K-2, although MK-4 exhibited a significantly greater efficiency compared to MK-7. In contrast, the same dose of vitamin K-1 had no inhibitory effect on RANKL-induced osteoclast cell formation, but increased the expression of major osteoclastogenic genes. Interestingly, vitamins K-1, MK-4 and MK-7 all strongly inhibited osteoclastic bone resorption (p < 0.01) in a dose dependent manner. These results suggest that vitamins K-1, MK-4 and MK-7 have anti-osteoporotic properties, while their regulation effects on osteoclastogenesis are somewhat different.

  • 相关文献
作者其他论文 更多>>